11-66551574-A-C
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3
The NM_001104.4(ACTN3):c.309A>C(p.Lys103Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,614,018 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001104.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTN3 | ENST00000513398.2 | c.309A>C | p.Lys103Asn | missense_variant | Exon 3 of 21 | 1 | NM_001104.4 | ENSP00000426797.1 | ||
ACTN3 | ENST00000502692.5 | c.438A>C | p.Lys146Asn | missense_variant | Exon 3 of 21 | 2 | ENSP00000422007.1 | |||
ACTN3 | ENST00000511191.1 | n.*276A>C | non_coding_transcript_exon_variant | Exon 3 of 5 | 5 | ENSP00000426236.1 | ||||
ACTN3 | ENST00000511191.1 | n.*276A>C | 3_prime_UTR_variant | Exon 3 of 5 | 5 | ENSP00000426236.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152220Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000200 AC: 5AN: 250190 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461798Hom.: 1 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727188 show subpopulations
GnomAD4 genome AF: 0.000112 AC: 17AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74368 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.309A>C (p.K103N) alteration is located in exon 3 (coding exon 3) of the ACTN3 gene. This alteration results from a A to C substitution at nucleotide position 309, causing the lysine (K) at amino acid position 103 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at